Home/Top Cited Articles

Top Cited Articles

Acceptance rate:
Impact Factor (JCR):
IF rank (Oncology):
IF rank (Immunology):
Total content views:
1.12 million

Top Cited Articles (Published 2021 - 2022)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events Brahmer, Julie R.; Abu-Sbeih, Hamzah; Ascierto, Paolo Antonio; et al 10.1136/jitc-2021-002435 Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future Alzeibak, Razan; Mishchenko, Tatiana A.; Shilyagina, Natalia Y.; et al 10.1136/jitc-2020-002038 Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? Demaria, Sandra; Guha, Chandan; Schoenfeld, Jonathan; et al 10.1136/jitc-2020-002038 STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation Nakamura, Takashi; Sato, Takanori; Endo, Rikito; Sasaki, Shun; et al 10.1136/jitc-2021-002852 Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies Nishikawa, Hiroyoshi; Koyama, Shohei 10.1136/jitc-2021-002591 Acute kidney injury in patients treated with immune checkpoint inhibitors Gupta, Shruti; Short, Samuel A. P.; Sise, Meghan E.; Prosek, Jason M.; et al 10.1136/jitc-2021-003467 Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy Cortellini, Alessio; Di Maio, Massimo; Nigro, Olga; Leonetti, Alessandro; et al 10.1136/jitc-2021-002421 Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial Ferris, Robert L.; Spanos, William C.; Leidner, Rom; Goncalves, Anthony; et al 10.1136/jitc-2021-002568 Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer Liu, Chao; Liu, Ruiqi; Wang, Bojun; Lian, Jie; et al 10.1136/jitc-2020-001895 Rethinking immune checkpoint blockade: 'Beyond the T cell' Liu, Xiuting; Hogg, Graham D.; DeNardo, David G. 10.1136/jitc-2020-001460
Severity of COVID-19 in patients with lung cancer: evidence and challenges Passaro, Antonio; Bestvina, Christine; Velez, Maria Velez; et al 10.1136/jitc-2020-002266 Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1 Yin, Zi; Yu, Min; Ma, Tingting; Zhang, Chuanzhao; Huang, Shanzhou; et al 10.1136/jitc-2020-001698 Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer Melisi, Davide; Oh, Do-Youn; Hollebecque, Antoine; Calvo, Emiliano; et al 10.1136/jitc-2020-002068 CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer Yang, Moran; Lu, Jiaqi; Zhang, Guodong; Wang, Yiying; et al 10.1136/jitc-2020-001136 Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer Zeng, Dongqiang; Wu, Jiani; Luo, Huiyan; Li, Yong; et al 10.1136/jitc-2021-002467 Intratumoral CD103+CD8+T cells predict response to PD-L1 blockade Banchereau, Romain; Chitre, Avantika S.; Scherl, Alexis; et al 10.1136/jitc-2020-002231 Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC) Ricciuti, Biagio; Jones, Greg; Severgnini, Mariano; et al 10.1136/jitc-2020-001504 Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images Mu, Wei; Jiang, Lei; Shi, Yu; Tunali, Ilke; et al 10.1136/jitc-2020-002118 Off-the-shelf V delta 1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma Makkouk, Amani; Yang, Xue (Cher); Barca, Taylor; et al 10.1136/jitc-2021-003441 HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy Marcu, Ana; Bichmann, Leon; Kuchenbecker, Leon; Kowalewski, Daniel Johannes; et al 10.1136/jitc-2020-002071